Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update

J Thromb Thrombolysis. 2017 May;43(4):528-529. doi: 10.1007/s11239-017-1485-1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Intravenous
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Dabigatran / antagonists & inhibitors*
  • Dabigatran / therapeutic use
  • Humans
  • Stroke / drug therapy*
  • Thrombolytic Therapy / methods*

Substances

  • Antibodies, Monoclonal, Humanized
  • idarucizumab
  • Dabigatran